ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PYC Physiomics Plc

1.50
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.50 1.40 1.60 1.50 1.50 1.50 195,426 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -4.29 2.03M
Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 1.50p. Over the last year, Physiomics shares have traded in a share price range of 0.925p to 3.15p.

Physiomics currently has 135,472,478 shares in issue. The market capitalisation of Physiomics is £2.03 million. Physiomics has a price to earnings ratio (PE ratio) of -4.29.

Physiomics Share Discussion Threads

Showing 24051 to 24071 of 30125 messages
Chat Pages: Latest  965  964  963  962  961  960  959  958  957  956  955  954  Older
DateSubjectAuthorDiscuss
28/5/2020
12:31
He clearly got hooked in at a much higher share price and is not a happy bunny!!
billthebank
28/5/2020
12:13
Spacedust, you had the opportunity to sell at 10p on 29th April but by then you had switched into bull mode.....

spacedust 28 Apr '20 - 16:07 - 4875 of 5473

Don't sell at 8.2p h9ld on til 16.5p so you double. I've requested this to finish 10p on close and 100% rise first thing tomorrow

You must be confident of 16p then if 10p was not good enough price.....

bones
28/5/2020
12:11
You can always buy below fundraise price when the share price goes below the placing price.

Now some smart assesses will say 3.5p is the floor and why would the share price go below the placing price

spacedust
28/5/2020
11:51
Fund raise at 3.5p, Can still buy under 4p.
What's not to like.

mam fach
28/5/2020
11:24
Unless JC aka ZA this shttt share with undisclosed fee contracts ain't going nowhere.

Cunning must step down

spacedust
28/5/2020
09:11
This will bounce
volsung
27/5/2020
20:58
Yes and it works everytime for the crooks.

I just want out of this shttt aim shares. I have three left

Pyc
Sar
And tly but tly are solid producing profits and paying dividends.

Over the past couple of yrs I've been coming out of aim shares and invest in ftse 100 and 250 companies and I've done a lot better. So I'm going to stick to that.

Next step sell PoooYC and Sar and never invest in aim shares ever again

spacedust
27/5/2020
14:40
He won't stop it and he can't.

Stig has a been pumping ramping this shttt share or 3yrs non stop

Only hope is jc

spacedust
27/5/2020
14:29
This should apply to all those R&D on twitter, seems only powerful people can stop it

hxxps://www.ndtv.com/world-news/donald-trump-threatens-to-close-down-social-media-after-twitter-fact-checks-his-tweets-2236079

euclid5
27/5/2020
13:18
Who needs analysis when they have you fantasising over how much each and every company you invest in is worth.
cocker
27/5/2020
13:16
Cunning jim couldvesuly sell his 3.5p discounted batch at 3.85p and make 10% profit.

A lot of pyc contracts are UNDISCLOSED FEE.

What a cunning piece of asssswipe cunning thief is. Jim the cunning

spacedust
27/5/2020
12:25
Downward dog sorry folks
chesty1
27/5/2020
10:20
Added a further 100k at 3.79. Well hidden by a public quote of 3.7-4.1
bones
27/5/2020
10:19
If this Big Pharma contract is similar to Merck then PYC's revenues will jump to over £1m p.a.

Given industry revenue multiples of 15-30x that should imply valuation of £15-30m or 15-30p a share

That's for the core Modelling and Simulation business

I believe the AI/ML Personalised Medicine (which they refer to as the blue sky growth part) is worth £50m+

the stigologist
27/5/2020
10:15
One of the problems PYC Physiomics has had getting the respect/valuation it deserves has been the lack of a decent UK quoted comparitor to help analysts and investors gain a better understanding of the market it operates in, the industry dynamics and the appropriate valuation benchmark

Although there still remains no viable UK comparitor in recent months an interesting US comparitor has emerged which may help Investors understanding and appreciation of PYC

What is interesting is that this is no ordinary comparitor. This Company has been described by Citron Research as a 'Tesla type' industry disruptor, the most important IPO in the last 5 years and has Bill Gates and D.E.Shaw as major cornerstone investors (together owning c.50%). Citron Research are mainly known as a specialist 'Bear' research house often debunking 'hot' stocks so it's interesting that they are so positive on this particular concept stock.

The stock in question is SDGR Schrodinger a Company founded in 1990, the current CEO joined in c.2002. It has taken them up now to IPO (February 2020) since when the stock has tripled ! ($17 to $55) and the Company is currently valued at over 30x (yes THIRTY times!) Revenue (2019 revenue $86m ; Mkt Cap $2.7bn)

The underlying story of Schrodinger is that of applying computer modelling techniques to drug discovery. Global Pharma/Biotech spends c.$180bn a year on R&D. So SDGR has a potentially huge market still left to penetrate.

Faced with a US tech comparitor the usual response from UK cuck analysts/Fund Managers is 'well US equity investors apply higher ratings to US stocks that's just the way it is'

However there is very good reason to make the case that Physiomics should not only be valued at 30x revenue but could deserve a premium!

SDGR is valued at 30x Revenue because US investors believe it has a wide open growth opportunity to eat into the $180bn Global Pharma R&D market opportunity

If US investors are prepared to pay so much for future growth how much would PYC be worth as a 'growth option' acquisition for either SDGR or a peer such as Private Equity roll-up Certara ?

- PYC would give SDGR access to computer based modelling and simulation expertise in the Drug Development part of the R&D cycle rather then just Drug Discovery
- PYC would give SDGR access to European geography
- PYC would give SDGR access to customers SDGR might not otherwise have access to (Merck, Bicycle Therapeutics)

Applying a 30x valuation to PYC's trailing 12 month revenues would imply a valuation of £23m (compared to the current £2.9m) a share price of 32.5p versus current 4p

NB : That valuation applied to Physiomics 'bread and butter' modelling and simulation business which is analagous to Schrodinger.
Physiomics also have a 'blue sky' story in utilising their Virtual Tumour cancer modelling expertise to offer a 'Business to Consumer' Universal Cancer Decision Support System through NHS/Clinicians which could be worth... well name your price. UK unicorns in AI/ML pharma/bio space are valued at Billions on zero revenue.

the stigologist
27/5/2020
10:15
I think it's now 3 massive inflection points for PYC story

1. Getting another Big Pharma contract
2. Getting a proper Institutional Investor on board
3. Getting a highly regarded market comparitor so people understand what you do/industry dynamics better

the stigologist
27/5/2020
10:06
I can’t see how you can go too far wrong at this level. Bought 250k this morning at average 3.85, just 10% above placing price. Seeing how this share can move like manure from the shovel on not a lot (see recent move to 10p), the risk/reward odds look ok to me.
bones
27/5/2020
09:31
Like I said cunning jim
spacedust
27/5/2020
09:31
AVCT Management own less than 1% of the shares in AVCT
the stigologist
27/5/2020
09:04
Yes probably another undisclosed fee contract. Stupid twits crooks. Cunning jim
spacedust
27/5/2020
08:45
Yes EG

Chart incoming

the stigologist
Chat Pages: Latest  965  964  963  962  961  960  959  958  957  956  955  954  Older

Your Recent History

Delayed Upgrade Clock